NCT01007253 - Effect of Veramyst and Olopatadine 0.2% Opthalmic Solution on Allergy Symptoms | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

April 30, 2010

Study Completion Date

August 31, 2011

Conditions

Seasonal Allergic Rhinitis

Interventions

DRUG

PL nasal spray

2 puffs of PL nasal spray (from GlaxoSmithKline) in each nostril once a day for 1 week

DRUG

fluticasone furoate (FF)

2 puffs of FF nasal spray in each nostril once a day for 1 week

DRUG

PL eye drops

1 drop of placebo eye drops (lubricant eye drops with active ingredients 0.3% glycerin) in each eye once a day for 1 week

DRUG

olopatadine (OLO)

1 drop of OLO eye drops in each eye once a day for 1 week

Trial Locations (1)

The University of Chicago, Chicago